Leap Therapeutics
Jack Warsh is a seasoned professional in financial planning and analysis, currently serving as Senior Manager at Leap Therapeutics since August 2022, previously holding the role of Manager. Prior experience includes a Business Development MBA internship at Formulate Bioscience, Inc. and several roles at Ceres Nanosciences, Inc. including Project Manager, Research and Development Specialist, and Research Technician. Earlier experience encompasses a position as a Biotech Analyst at Warberg Asset Management and an Organic Chemistry Research Assistant role at the Michigan State Chemistry Department. Jack Warsh holds an MBA from Georgetown University McDonough School of Business (2020-2022) and multiple Bachelor of Science degrees in Biochemistry and Molecular Biology/Biotechnology from Michigan State University (2011-2015).
Leap Therapeutics
1 followers
Leap Therapeutics (NASDAQ: LPTX) is a clinical-stage biopharmaceutical company acquiring and developing novel therapeutics at the leading edge of cancer research.